Profile data is unavailable for this security.
About the company
Venus Concept Inc. is a global medical aesthetic technology company. The Company has a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches in over 60 countries and 14 direct markets. The Company's product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Glow, Venus Bliss, Venus BlissMAX, Venus Epileve, Venus Viva MD and AI.ME. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. The Company's systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry's traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family and general practitioners and aesthetic medical spas. The Company's hair loss treatment solutions include the ARTAS Solution and the NeoGraft Solution.
- Revenue in USD (TTM)73.30m
- Net income in USD-37.39m
- Incorporated2002
- Employees304.00
- LocationVenus Concept Inc235 Yorkland Blvd Suite 900TORONTO M2J 4Y8CanadaCAN
- Phone+1 (408) 883-6888
- Fax+1 (302) 655-5049
- Websitehttps://www.venusconcept.com/en-uk/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Invo Bioscience Inc | 4.25m | -7.08m | 3.12m | 25.00 | -- | -- | -- | 0.7351 | -5.68 | -5.68 | 2.59 | 0.0039 | 0.3473 | 9.50 | 30.72 | 169,953.20 | -57.87 | -94.63 | -128.00 | -151.45 | 39.90 | 74.91 | -166.64 | -343.11 | 0.1629 | -5.86 | 0.9965 | -- | 267.38 | 43.62 | 26.24 | -- | 87.09 | -- |
| Therapeutic Solutions International Inc | 97.68k | -2.18m | 3.21m | 3.00 | -- | 2.10 | -- | 32.90 | -0.0006 | -0.0006 | 0.00003 | 0.0003 | 0.0257 | 1.30 | 5.44 | 32,560.00 | -63.47 | -162.32 | -172.17 | -- | 63.36 | 67.79 | -2,468.37 | -2,391.85 | 0.4652 | -6.42 | 0.2868 | -- | -52.13 | 95.35 | 43.11 | -- | -- | -- |
| Fuse Medical Inc | 18.40m | 3.63m | 3.33m | 31.00 | 1.25 | -- | 0.9016 | 0.1807 | 0.036 | 0.036 | 0.2307 | -0.0031 | 0.9593 | 0.7018 | 5.75 | 593,671.90 | 18.91 | 0.7504 | 48.45 | 1.35 | 64.95 | 54.98 | 19.72 | 0.6552 | 0.3143 | -1.13 | 1.12 | -- | -8.67 | -6.72 | 295.11 | 34.66 | -- | -- |
| Applied DNA Sciences Inc | 5.52m | -12.50m | 3.70m | 53.00 | -- | -- | -- | 0.6698 | -17.13 | -17.13 | 7.67 | -0.0558 | 0.3893 | 10.38 | 4.64 | 104,110.80 | -87.15 | -88.57 | -111.09 | -121.91 | 33.98 | 44.35 | -223.89 | -113.26 | 1.54 | -- | -- | -- | -26.43 | 27.92 | -18.73 | -- | 33.80 | -- |
| AccuStem Sciences Inc | 0.00 | -1.74m | 3.90m | 3.00 | -- | -- | -- | -- | -0.1537 | -0.1537 | 0.00 | -0.2309 | 0.00 | -- | -- | 0.00 | -1,168.46 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 45.26 | -- | -- | -- |
| SINTX Technologies Inc | 2.78m | -8.88m | 3.94m | 43.00 | -- | 0.0138 | -- | 1.42 | -389.94 | -389.94 | 74.21 | 383.24 | 0.138 | 1.62 | 5.84 | 64,534.88 | -44.03 | -45.71 | -57.11 | -57.36 | 67.96 | 58.47 | -318.99 | -681.80 | 1.67 | -- | 0.0229 | -- | 68.29 | 94.24 | 49.75 | -- | 54.10 | -- |
| Arch Therapeutics Inc | 130.55k | -8.43m | 4.00m | 8.00 | -- | -- | -- | 30.64 | -3.68 | -3.68 | 0.0425 | -2.45 | 0.0833 | 0.0637 | -- | 16,318.75 | -538.25 | -188.28 | -- | -804.63 | 33.37 | -- | -6,458.14 | -26,945.92 | 0.0164 | -1.27 | -- | -- | 383.83 | -- | -32.35 | -- | -21.76 | -- |
| Venus Concept Inc | 73.30m | -37.39m | 4.07m | 304.00 | -- | -- | -- | 0.0555 | -6.69 | -6.69 | 13.12 | -3.54 | 0.7409 | 1.06 | 2.21 | 241,125.00 | -37.61 | -32.71 | -56.83 | -44.01 | 68.37 | 68.16 | -50.77 | -48.50 | 1.35 | -3.44 | 1.40 | -- | -23.26 | 28.31 | 14.76 | -- | -35.08 | -- |
| Encision Inc | 6.59m | -691.78k | 4.27m | 22.00 | -- | 2.34 | -- | 0.6489 | -0.0588 | -0.0588 | 0.5595 | 0.154 | 1.66 | 2.09 | 7.27 | 299,357.70 | -17.41 | -3.03 | -24.73 | -4.13 | 47.62 | 51.25 | -10.50 | -1.89 | 0.8393 | -10.27 | 0.1272 | -- | -10.38 | -5.64 | -113.55 | -- | -9.54 | -- |
| Dror Ortho-Design Inc | 0.00 | -4.83m | 4.46m | 4.00 | -- | 1.87 | -- | -- | -0.0115 | -0.0115 | 0.00 | 0.0048 | 0.00 | -- | -- | -- | -357.10 | -140.50 | -595.21 | -- | -- | -- | -- | -118,188.00 | -- | -- | 0.00 | -- | -- | -- | -1,896.02 | -- | -- | -- |
| Sharps Technology Inc | 0.00 | -8.71m | 4.54m | 3.00 | -- | 0.6615 | -- | -- | -0.6204 | -0.6204 | 0.00 | 0.4378 | 0.00 | -- | -- | -- | -74.67 | -- | -95.84 | -- | -- | -- | -- | -- | 0.492 | -- | 0.00 | -- | -- | -- | -112.12 | -- | -- | -- |
| Reflect Scientific Inc | 1.27m | -343.17k | 4.67m | 7.00 | -- | 2.51 | -- | 3.68 | -0.004 | -0.004 | 0.0148 | 0.0217 | 0.5129 | 0.6184 | 5.72 | 181,111.40 | -13.88 | 11.10 | -16.43 | 13.21 | 56.06 | 62.48 | -27.07 | 10.00 | 2.21 | -- | 0.00 | -- | -47.09 | -6.99 | -613.46 | -- | -- | -- |
| ReShape Lifesciences Inc | 8.34m | -10.92m | 4.73m | 31.00 | -- | 1.04 | -- | 0.5674 | -2.30 | -2.30 | 0.7319 | 0.1933 | 0.6781 | 0.8178 | 4.52 | 268,871.00 | -88.83 | -136.06 | -162.20 | -194.32 | 65.85 | 56.30 | -130.99 | -408.36 | 1.26 | -- | 0.00 | -- | -22.79 | -0.9474 | 75.36 | -- | -49.29 | -- |
| Nu-Med Plus Inc | 0.00 | -119.16k | 4.75m | 2.00 | -- | -- | -- | -- | -0.0014 | -0.0014 | 0.00 | -0.002 | 0.00 | -- | -- | 0.00 | -350.01 | -447.69 | -- | -- | -- | -- | -- | -- | -- | -22.74 | -- | -- | -- | -- | 3.56 | -- | -- | -- |
| Aethlon Medical, Inc. | 0.00 | -12.21m | 5.11m | 14.00 | -- | 0.1676 | -- | -- | -4.87 | -4.87 | 0.00 | 2.19 | 0.00 | -- | -- | 0.00 | -94.80 | -76.25 | -108.90 | -85.78 | -- | -- | -- | -2,246.87 | -- | -- | 0.00 | -- | -100.00 | -- | -1.43 | -- | -- | -- |
Data as of Jul 29 2024. Currency figures normalised to Venus Concept Inc's reporting currency: US Dollar USD
24.80%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Masters Capital Management LLCas of 11 Jun 2024 | 1.05m | 16.52% |
| SEDCO Capital Co.as of 24 Mar 2023 | 417.06k | 6.56% |
| Two Sigma Securities LLCas of 31 Mar 2024 | 36.76k | 0.58% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 32.44k | 0.51% |
| Geode Capital Management LLCas of 31 Mar 2024 | 21.09k | 0.33% |
| PFG Investments LLCas of 31 Mar 2024 | 11.00k | 0.17% |
| Tower Research Capital LLCas of 31 Mar 2024 | 7.01k | 0.11% |
| Securities America Advisors, Inc.as of 31 Mar 2024 | 401.00 | 0.01% |
| Pacifica Partners, Inc.as of 30 Jun 2024 | 254.00 | 0.00% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Mar 2024 | 246.00 | 0.00% |
More ▼
Data from 20 Mar 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
